Local recommendations (Cardiovascular)


Recommendation Approval date Review date
Hydrochlorothiazide EKPG EKHUFT February 2019 February 2022


Hypertension and Heart Failure

Recommendation Approval date Review date
EKPG Recommendation - Sacubitril Valsartan November 2016 November 2019
Sacubitril Valsartan GP letter June 2016 April 2021
Sacubitril valsartan GP summary June 2016 April 2021
Midodrine prescribing information sheet (V2) April 2016 April 2021
B195. Doxazosin MR 2.0 January 2018 January 2021


Nitrates, calcium-channel blockers, and other antianginal drugs

Recommendation Approval date Review date
Chronic Heart Failure -ECK Ivabradine NICE TA 267 July 2015 April 2021


Lipid modifying drugs

Recommendation Approval date Review date
Alirocumab & Evoculumab, GP update on Implementation of NICE TAs 393 & 394 November 2017 November 2020
EKPG Recommendation - Evolocumab and alirocumab for hypercholesterolaemia April 2017 April 2020


Antithrombotic drugs

Recommendation Approval date Review date
Enoxaparin pre surgery EKPG recommendation July 2015 April 2021
EKPG Recommendation - NOACs - DVT PE treatment August 2018 August 2021

Non-valvular Atrial Fibrillation- prevention of stroke and systemic embolism in adults- anticoagulation decision making tool

March 2018 March 2021
Ticagrelor for the prevention of atherothrombotic events in adult patients with ACS, EKPG August 2013 April 2021
EKPG Recommendation - Argatroban for type 2 heparin-induced thrombocytopenia March 2017 March 2020


General (Cardio)

Recommendation Approval date Review date
Rituximab for the treatment of immune thrombocytopenic purpura, EKPG Recommendation December 2015 April 2021

This website is currently under development. Documents in the ‘Local Recommendations’ pages in each Therapeutic Section are current but the drug pages are still under construction. For the current East Kent formulary please see the note on the homepage.